These agents are likely to become the mainstay of cancer treatment in the very near future.
Francis Staskon, PhD
Advertisement
Articles by Francis Staskon, PhD
Advertisement
Latest Updated Articles
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer HospitalizationsPublished: February 7th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
FDA Approves 1-Minute HIV Self-Test
4
Young Women With Symptomatic Long COVID At Higher Risk of POTS
5
